Mammalian Manufacturing Solutions: End-To-End Manufacturing Capabilities

From cell banking and process development through commercial-scale production and analytical testing, Novartis Contract Manufacturing supports mammalian biologics across the manufacturing lifecycle. Its global network offers fed-batch, perfusion, and continuous processing, with both single-use and stainless-steel bioreactors suited to small- and large-scale requirements.

Facilities across Austria, France, Slovenia, Switzerland, and Singapore provide capabilities for monoclonal antibodies, bi- and multispecific antibodies, therapeutic proteins, and enzymes. Clients also gain access to process characterization, comparability studies, environmental monitoring, bioassays, and stability testing. Backed by more than 40 years of GMP manufacturing experience and over 20 manufacturing sites worldwide, the network is designed to deliver reliable capacity and supply continuity.

Explore the brochure to identify the capabilities and locations that align with your manufacturing strategy.